S&P 500
(0.29%) 5 114.76 points
Dow Jones
(0.30%) 38 356 points
Nasdaq
(0.31%) 15 977 points
Oil
(-0.92%) $83.08
Gas
(5.77%) $2.03
Gold
(0.37%) $2 355.80
Silver
(0.44%) $27.66
Platinum
(4.00%) $959.00
USD/EUR
(-0.22%) $0.933
USD/NOK
(-0.38%) $10.98
USD/GBP
(-0.55%) $0.796
USD/RUB
(1.69%) $93.43

リアルタイムの更新: Akoya Biosciences, Inc. [AKYA]

取引所: NASDAQ セクター: Healthcare 産業: Medical Instruments & Supplies
BUY
75.00%
return 5.78%
SELL
0.00%
return 14.02%
最終更新日時30 4月 2024 @ 01:32

1.32% $ 3.85

売る 107810 min ago

@ $5.47

発行日: 15 2月 2024 @ 04:51


リターン: -29.62%


前回のシグナル: 2月 15 - 02:36


前回のシグナル: 買う


リターン: 1.86 %

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:32):
Profile picture for Akoya Biosciences, Inc.

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa...

Stats
本日の出来高 19 624.00
平均出来高 180 475
時価総額 190.11M
EPS $0 ( 2024-03-04 )
次の収益日 ( $-0.300 ) 2024-05-13
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.69
ATR14 $0.00800 (0.21%)
Insider Trading
Date Person Action Amount type
2024-04-01 Ek John Frederick Sell 14 272 Common Stock
2024-03-23 Pla Frederic Sell 2 006 Common Stock
2024-03-23 Ramachandran Niro Ph.d Sell 2 006 Common Stock
2024-03-23 Mckelligon Brian Sell 7 135 Common Stock
2024-03-20 Mckelligon Brian Sell 7 500 Employee Stock Option (Right to Buy)
INSIDER POWER
67.46
Last 99 transactions
Buy: 5 199 597 | Sell: 937 556

ボリューム 相関

長: 0.06 (neutral)
短: 0.21 (neutral)
Signal:(57.112) Neutral

Akoya Biosciences, Inc. 相関

10 最も正の相関
MTLS0.969
FATE0.966
IHRT0.965
CUE0.965
EAR0.962
CBAN0.961
SSBK0.96
PNFP0.959
FGBI0.959
FNCB0.958
10 最も負の相関
OHAA-0.95
BRIVU-0.942
NVCN-0.942
PRDO-0.94
PPYAU-0.939
MSDA-0.939
HDSN-0.932
SENEA-0.93
TIOA-0.928
XFIN-0.928

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Akoya Biosciences, Inc. 相関 - 通貨/商品

The country flag -0.14
( neutral )
The country flag 0.08
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.18
( neutral )
The country flag -0.35
( neutral )

Akoya Biosciences, Inc. 財務諸表

Annual 2023
収益: $96.63M
総利益: $48.24M (49.92 %)
EPS: $-1.430
FY 2023
収益: $96.63M
総利益: $48.24M (49.92 %)
EPS: $-1.430
FY 2022
収益: $74.86M
総利益: $43.39M (57.96 %)
EPS: $-1.870
FY 2021
収益: $54.92M
総利益: $13.52M (24.62 %)
EPS: $-1.485

Financial Reports:

No articles found.

Akoya Biosciences, Inc.

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。